Future Science Group
Browse
Supplementary_Appendix.docx (692.24 kB)
Download file

Surrogate end points for survival in patients with advanced hepatocellular carcinoma treated with immune checkpoint inhibitors. Supplementary material.

Download (692.24 kB)
figure
posted on 2022-10-26, 08:40 authored by Abhijoy Saha, Ryan C Widau, David Ferry, Yong Lin, Andrew X. Zhu

  

Supplemental Figure 1A.

Scatterplot of the relationship between treatment arms for overall response rate and median overall survival excluding phase III COSMIC-312 study

  

Supplemental Figure 1B.

Scatterplot of the relationship between treatment arms for overall response rate and median progression-free survival excluding phase III COSMIC-312 study


Supplemental Figure 1C.

Scatterplot of the relationship between treatment arms for median progression-free survival and median overall survival excluding phase III COSMIC-312 study

History

Usage metrics

    Immunotherapy

    Categories

    Keywords

    surrogate end pointsProgression-free survivalOverall survivalobjective response rate (ORR)hepatocellular carcinomaImmune Checkpoint Inhibitors

    Licence

    CC BY-NC-ND 4.0

    Exports